Skip To Main Content
Bruno Bariohay on Muck Rack

Bruno Bariohay

As seen in: Cell Reports Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bruno

Contact Bruno, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans

|
By Henning Tim Langer, Natalie Gilmore, Christopher Hayden, Julien Roux, Bruno Bariohay, Thaïs Rouquet, Manar Awada, Julie Marcotorchino, Lorrine Bournot, Elizabeth R. Nunn, Paul M. Titchenell, Daniela Liskiewicz, Timo Müller, Oluwaseun Anyiam, Philip J Atherton, Iskandar Idris, Andreas Hentschel Verified, Andreas Roos, Natalie Haritonow, Kristina Norman, Ursula Müller-Werdan, Keith Baar
| Cell Reports Medicine Verified
Keywords GLP-1 muscle loss obesity incretins wasting weight loss atrophy function muscle mass Introduction Globally, over 1 billion people suffer from obesity.1 Incretin-based drugs offer a powerful treatment option for patients with obesity (PWO).
Open in Who Shared Issue with article?
See all 1 articles